Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,500 | 160,700 | 179,400 | 203,700 | 285,300 |
| Receivables | 1,060,800 | 1,212,300 | 1,079,800 | 1,101,900 | 1,206,200 |
| Inventories | 2,091,000 | 2,162,200 | 2,173,800 | 2,047,600 | 2,279,000 |
| Other current assets | 426,100 | 432,900 | 458,900 | 427,700 | 449,400 |
| TOTAL | $3,753,400 | $3,968,100 | $3,891,900 | $3,780,900 | $4,219,900 |
| Non-Current Assets | |||||
| PPE Net | 1,613,500 | 1,676,700 | 1,701,200 | 1,698,200 | 1,938,700 |
| Investments And Advances | 45,900 | 85,100 | 200,800 | 110,000 | 182,400 |
| Intangibles | 7,656,100 | 7,835,700 | 8,153,000 | 8,063,200 | 8,430,200 |
| Other Non-Current Assets | 271,000 | 292,400 | 217,600 | 304,600 | 283,400 |
| TOTAL | $9,586,500 | $9,889,900 | $10,272,600 | $10,176,000 | $10,834,700 |
| Total Assets | $13,339,900 | $13,858,000 | $14,164,500 | $13,956,900 | $15,054,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 425,900 | 472,900 | 676,500 | 200,000 | 200,100 |
| Accounts payable and accrued liabilities | 414,600 | 429,700 | 445,500 | 468,900 | 449,300 |
| Accrued Expenses | 713,200 | 675,800 | 587,400 | N/A | 901,700 |
| Other current liabilities | N/A | N/A | N/A | 1,194,000 | N/A |
| TOTAL | $2,574,000 | $2,330,800 | $2,496,800 | $2,093,900 | $2,693,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,484,600 | 3,563,100 | 3,569,600 | 3,942,700 | 4,659,900 |
| aiOther Non-Current Liabilities | 678,400 | 1,203,800 | 1,212,000 | 1,218,300 | 1,274,099 |
| TOTAL | $5,111,800 | $5,655,700 | $5,784,200 | $6,177,500 | $7,047,699 |
| Total Liabilities | $7,685,800 | $7,986,500 | $8,281,000 | $8,271,400 | $9,741,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,907 | 149,919 | 153,688 | 154,031 | 153,814 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 7,327,900 | 7,125,800 | 7,054,600 | 6,999,300 | 6,797,700 |
| Other shareholders' equity | 213,200 | 510,200 | 475,800 | 354,900 | 194,500 |
| TOTAL | $5,654,100 | $5,871,500 | $5,883,500 | $5,685,500 | $5,313,100 |
| Total Liabilities And Equity | $13,339,900 | $13,858,000 | $14,164,500 | $13,956,900 | $15,054,600 |